Search results for

The aim is to make clinical trial data available to volunteers and scientists, even if a drug or therapy being tested turns out to be a failure. That could help identify serious side effects.

NPR's Scott Simon and Tom Goldman discuss the Cubs and the curse, the Paralympic games in Rio, and one wheelchair racer who is stirring up a discussion about euthanasia.

Edward Snowden is having a big week, as the subject of both a laudatory new Oliver Stone biopic and a scathing report from the House Intelligence Committee. We examine the competing narratives.

David Greene talks to Espin Egil Hansen, a newspaper editor in Norway, who says Facebook needs to admit it is a powerful editor, and has to take more responsibility for its editorial decisions.

Drug resistance is no longer a matter of health. It could have massive implications for the world's economy and food supply.

Sutherland plays a Cabinet member who becomes president after an explosion takes out the U.S. Capitol — and everyone above him in the pecking order. Critic John Powers has a review.

In the latest conversation marking the centenary of the Pulitzers, NPR's Scott Simon asks Gregory Pardlo what it means for a poet to win the prize and how it affects his poetry.

Seventeen states have legal protections to prevent discrimination against transgender people in areas like housing and employment. But just having a law on the books doesn't change people's attitudes.

He can do it through a joint fundraising apparatus for his campaign, the Republican National Committee and 11 state Republican parties. It's something Hillary Clinton has been doing since last year.

The city, condemned in the Bible and a source of black magic in the Quran, has been ravaged by war and neglect. For decades, preservationists have pushed for the site to be restored.